Laboratorios Farmaceuticos ROVI (ROVI) — Cash Flow-to-Debt Ratio
Laboratorios Farmaceuticos ROVI (ROVI) has a Cash Flow-to-Debt Ratio of 0.25x as of September 2025, meaning its operating cash flow of €73.37 Million could theoretically repay 0% of its total liabilities (€289.27 Million) in one year. Explore Laboratorios Farmaceuticos ROVI (ROVI) investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Laboratorios Farmaceuticos ROVI Cash Flow-to-Debt Ratio (2006–2024)
Historical debt coverage capacity for Laboratorios Farmaceuticos ROVI across 19 annual periods. Also explore total assets of Laboratorios Farmaceuticos ROVI for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Laboratorios Farmaceuticos ROVI (2006–2024)
Year-by-year debt coverage analysis for Laboratorios Farmaceuticos ROVI. For market capitalisation and broader financial context, see market value of Laboratorios Farmaceuticos ROVI.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.55x | €138.28 Million | €250.48 Million | ▲ +25.0% |
| 2023 | 0.44x | €113.25 Million | €256.39 Million | ▼ -33.6% |
| 2022 | 0.66x | €237.60 Million | €357.32 Million | ▲ +16.4% |
| 2021 | 0.57x | €149.44 Million | €261.70 Million | ▲ +144.5% |
| 2020 | 0.23x | €46.88 Million | €200.74 Million | ▲ +587.5% |
| 2019 | -0.05x | €-9.04 Million | €188.82 Million | ▼ -164.7% |
| 2018 | 0.07x | €8.53 Million | €115.23 Million | ▼ -56.2% |
| 2017 | 0.17x | €18.04 Million | €106.69 Million | ▼ -61.2% |
| 2016 | 0.44x | €45.53 Million | €104.44 Million | ▲ +46.9% |
| 2015 | 0.30x | €29.39 Million | €99.06 Million | ▲ +32.7% |
| 2014 | 0.22x | €23.00 Million | €102.85 Million | ▼ -31.4% |
| 2013 | 0.33x | €29.82 Million | €91.46 Million | ▲ +59.4% |
| 2012 | 0.20x | €19.61 Million | €95.92 Million | ▲ +83.9% |
| 2011 | 0.11x | €12.68 Million | €114.09 Million | ▼ -42.9% |
| 2010 | 0.19x | €21.19 Million | €108.75 Million | ▲ +91.2% |
| 2009 | 0.10x | €9.62 Million | €94.42 Million | ▼ -42.0% |
| 2008 | 0.18x | €12.66 Million | €72.11 Million | ▲ +818.9% |
| 2007 | 0.02x | €1.15 Million | €60.23 Million | ▼ -87.6% |
| 2006 | 0.15x | €7.72 Million | €50.23 Million | — |